Manufacturing Facilities
Samsung BioLogics faces FDA scrutiny over data integrity and quality issues at Korean plant
The FDA recently issued manufacturing alerts, targeting high-flying companies Samsung Biologics and Nectar Lifesciences. For Samsung Biologics, a notable player ...
Bayer opens new $250M facility in Berkeley to launch its cell therapy products
In a significant move to address the challenges of scaling up the production of cell therapies, Bayer, through its subsidiary ...
Lotte Biologics to Construct 3 New Plants by 2030 After Land Purchase, Boosting Korean CDMO Capacity
Korean Contract Development and Manufacturing Organization (CDMO), Lotte Biologics, is embarking on an ambitious growth trajectory, aiming to achieve a ...
Eli Lilly settles Whistleblower lawsuit over alleged quality issues
Settlement talks have been underway between pharmaceutical giant Eli Lilly and a former human resources officer, Amrit Mula, who blew ...
Merck KGaA’s MilliporeSigma Invests €28 Million in 2 New mRNA Production Facilities
Merck KGaA’s MilliporeSigma has taken significant steps in its €1 billion initiative to establish a global mRNA network, enhancing its ...
Astellas to invest $354M in new Irish plant for antibody drugs
Astellas is strengthening its significant presence in Ireland with a substantial investment of 330 million euros ($354 million) in a ...
